Labcorp Holdings Inc. LH
NYSE · Healthcare · Medical - Diagnostics & Research
$367.13
Close on Fri, 20 Nov 2026 · market value $29.8B
What the price is betting on
In line with its recordAt $367, the price assumes revenue grows about 7.4% a year for five years, from $14.6B to about $19.8B by FY2030. That is about one and a half times what analysts expect for the next two years and about the same as the company's own last three years.
Revenue growth a year. The price figure comes from a reverse DCF at a 8.5% discount rate.
Track it and Parra checks each report against the path, and tells you when revenue falls behind it.
Own more than LH? Check up to 5 of your stocks at once, free, no account.
Both sides
Three stories, three values
Bear
$295
Base
$338
Bull
$386
Today $367
- Bear $295. Cash flow grows 4% a year for the next 5 years, slower than expected, then slows to long-run growth.
- Base $338. Cash flow grows 6% a year for the next 5 years, as analysts expect, then slows to long-run growth.
- Bull $386. Cash flow grows 8% a year for the next 5 years, faster than expected, then slows to long-run growth.
Stories set by rules from the company’s record.
Checkpoints
The revenue the price needs
- YearNeedsAnalysts expect
- FY2026$14.9B$14.8B, on the path
- FY2027$16B$15.6B, on the path
- FY2028$17.1B$16.4B, below the path
- FY2029$18.4B$17.7B, below the path
- FY2030$19.8B$15.2B, below the path
Each year's revenue at 7.4% growth from $14.6B in the 12 months to September 2026.
At a glance
Healthcare · Medical - Diagnostics & Research · listed on NYSE
- Revenue, FY2025
- $14B
- Growth, 3 years a year
- 6.9%
- Cash margin
- 8.6%
- Net debt
- $6B
- Shares, 3-year change
- −8.5%
- Dividend yield
- 0.8%
What other healthcare prices are betting on
Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.